Cencora (COR) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Cencora (COR) do?
Cencora Inc (COR) is a U.S.-listed company in Healthcare (Medical Distribution). What it does: Distributes prescription drugs, specialty medicines, and healthcare products to pharmacies and health systems worldwide. It purchases and delivers pharmaceuticals to hospitals, pharmacies, and clinics across global distribution networks. It is worth $65.12B on the market and sold $342.74B over the last year.
- Market cap
- $65.12B
- P/E ratio
- 19.1×
- Annual sales
- $342.74B
- Sector
- Healthcare
- Industry
- Medical Distribution
- Brief updated
- Nov 14, 2026
Brands and businesses behind COR
- Alliance Healthcare: It distributes pharmaceutical products to independent pharmacies and hospitals across Europe, earning fees on wholesale deliveries.
- World Courier: It provides temperature-controlled logistics for clinical trials and biopharma products, charging fees for specialized shipping and storage.
- Good Neighbor Pharmacy: It operates an independent pharmacy franchise network, earning membership fees and wholesale supply revenue from member stores.
- MWI Animal Health: It supplies animal health pharmaceuticals and supplies to veterinary practices and livestock producers, earning wholesale distribution revenue.
COR’s flags, in plain English
Each flag is a number from Cencora’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 14, 2026.
Earns Its Keep
Earns 134.3% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.
Capital Works Hard
Earns 23.6% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.
Still Climbing
Sales up 9.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Debt Is Driving
Heavy debt, 306% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about COR
How big is Cencora?
Cencora’s market cap is $65.12B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $342.74B: what customers paid the company over the last year, before any costs.
What is COR’s P/E ratio?
COR’s P/E ratio is 19.1×. Investors pay about 19.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with COR?
A single customer, Walgreens Boots Alliance, accounts for over ten percent of total company revenues. That is one risk on Cencora’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Cencora’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. COR’s filings on SEC.gov. The Margin Monkey is research, not advice.
